Active ingredientSamidorphanCat. No. P-S011-001CAS 852626-89-2Family · Pharmaceutical analytical standards
Samidorphan
An opioid receptor antagonist, approved in the United States in May 2021 in combination with olanzapine for schizophrenia and bipolar disorder: it helps limit the weight gain linked to the antipsychotic. This family brings together the active ingredient and other impurities.
Did you know?It has academic origins: it was designed starting from two known molecules, naltrexone and 8-carboxamidocyclazocine, and has also been studied against alcohol dependence.
Go to the active ingredient →Active ingredientSamidorphanCat. No. P-S011-001CAS 852626-89-2
Active ingredientSamidorphan L-malateCat. No. P-S011-005CAS 1204592-75-5
ImpuritySamidorphan N-OxideCat. No. P-S011-006CAS 2098343-52-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.